Results 1 to 10 of about 3,002,203 (306)

Repository

open access: yesProceedings of the SIGGRAPH Asia 2022 Art Gallery, 2022
Repository of the Francesca Manni thesis degree in Astronomy and Astrophysics, 2022/2023. This archive contains the Retrieval data of orbits 1 (North and South pole), 4, 7, 8, and 26 orbits (South pole). The files contain the following parameters: Spectrum number, Name of the analyzed file, Latitude, Longitude, Solar Zenith angle, χ^2, Column density ...
  +6 more sources

Mining Software Repositories with a Collaborative Heuristic Repository [PDF]

open access: yes2021 IEEE/ACM 43rd International Conference on Software Engineering: New Ideas and Emerging Results (ICSE-NIER), 2021
5 pages; to appear in Proceedings of ICSE NIER ...
Hlib Babii   +5 more
openaire   +2 more sources

The NanoFlow Repository

open access: yesBioinformatics, 2023
AbstractMotivationExtracellular particles (EPs) are the focus of a rapidly growing area of exploration due to the widespread interest in understanding their roles in health and disease. However, despite the general need for EP data sharing and established community standards for data reporting, no standard repository for EP flow cytometry data captures
Jessie E. Arce   +8 more
openaire   +3 more sources

The immune‐related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation

open access: yesCancer Cell International, 2021
Background High immunogenicity is an important feature of ccRCC, but its underlying immune-related molecular mechanisms remain unclear. This study aimed to investigate the effect of immune-related gene TEK on ccRCC and its prognostic value.
Siming Chen   +6 more
doaj   +1 more source

Pectolinarigenin inhibits bladder urothelial carcinoma cell proliferation by regulating DNA damage/autophagy pathways

open access: yesCell Death Discovery, 2023
Pectolinarigenin (PEC), an active compound isolated from traditional herbal medicine, has shown potential anti-tumor properties against various types of cancer cells.
Zhao Deng   +13 more
doaj   +1 more source

Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis

open access: yesCell Death and Disease, 2023
Melatonin is a well-known natural hormone, which shows a potential anticancer effect in many human cancers. Bladder cancer (BLCA) is one of the most malignant human cancers in the world.
Dexin Shen   +12 more
doaj   +1 more source

A desert lncRNA HIDEN regulates human endoderm differentiation via interacting with IMP1 and stabilizing FZD5 mRNA

open access: yesGenome Biology, 2023
Background Extensive studies have revealed the function and mechanism of lncRNAs in development and differentiation, but the majority have focused on those lncRNAs adjacent to protein-coding genes.
Pei Lu   +9 more
doaj   +1 more source

Urine‐based liquid biopsy in bladder cancer: Opportunities and challenges

open access: yesClinical and Translational Discovery, 2023
Bladder cancer (BLCA) is a most common urological tumours with high rate of recurrence, which needs long‐term of follow‐up. To date, diagnosis and surveillance of BLCA still rely on cystoscopy, an invasive and expensive method that increases the ...
Gang Wang   +12 more
doaj   +1 more source

E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability

open access: yesCell Death and Disease, 2021
E3 ubiquitin ligase RNF126 (ring finger protein 126) is highly expressed in various cancers and strongly associated with tumorigenesis. However, its specific function in bladder cancer (BCa) is still debatable.
Huimin Xu   +8 more
doaj   +1 more source

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma

open access: yesCancer Cell International, 2021
Background CDCA3 is an important component of the E3 ligase complex with SKP1 and CUL1, which could regulate the progress of cell mitosis. CDCA3 has been widely identified as a proto-oncogene in multiple human cancers, however, its role in promoting ...
Dexin Shen   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy